• 1
    Meldrum D, Mitchell MB, Banerjee A, Harken AH. Cardiac preconditioning. Arch Surg 1993; 128: 12081211.
  • 2
    Liang-Xiong Fu, Kirkeboen KA, Liang QM, Sjorgren KG, Hjalmarson A, Ilebekk A. Free radical scavenging enzymes and G protein mediated receptor signalling systems in ischaemically preconditioned porcine myocardium. Cardiovasc Res 1993; 27: 612616.
  • 3
    Parrat JR. Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation. Tips Reviews 1994; 15: 1925.
  • 4
    Villarreal D, Grisham MB, Granger DN. Nitric oxide donors improve gut function after prolonged hypothermic ischemia. Transplantation 1995; 59: 685689.
  • 5
    Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukotriene adhesion. Proc Natl Acad Sci U S A 1991; 88: 46514657.
  • 6
    Kubes P. Nitric oxide modulates epithelial permeability in feline small intestine. Am J Physiol 1992; 262: G1138G1144.
  • 7
    Jenkins DP, Batxer GF, Yellon DM. The pathophysiology of ischaemic preconditioning. Pharmacol Res 1995; 31: 219223.
  • 8
    Ramkumar V, Nie Z, Rybak LP, Maggiwar SB. Adenosine, antioxidant enzymes and cytoprotection. Trends Pharmacol Sci 1995; 16: 283285.
  • 9
    McKie LD, Bass BL, Dunkin BJ, Harmon JW. Nitric oxide mediates the blood flow response to intravenous adenosine in the rabbit. Circ Shock 1994; 43: 103106.
  • 10
    Li JM, Fenton A, Cutler BS, Dobson JM. Adenosine enhances nitric oxide production by vascular cells. Am J Physiol 1995; 269: C519C523.
  • 11
    Fischer H, Prast H, Philippu A. Adenosine release in the ventral striatum of the rat is modulated by endogenous nitric oxide. Eur J Pharmacol 1995; 275: R5R6.
  • 12
    Lloris JM, Cejalvo D, Toledo-Pereyra LH, Calvo MA, Suzuki S. Preconditioning: effect upon lesion modulation in warm liver ischemia. Transplant Proc 1993; 25: 33033304.
  • 13
    Seino Y, Ohki K, Nakamura T, Tsukamoto H, Takano T, Aramaki T, Okumura H, et al. Pathophysiological characteristics of cutaneous microcirculation in patients with liver cirrhosis: relationship to cardiovascular hemodynamics and plasma neurohormonal factors. Microvasc Res 1993; 46: 206215.
  • 14
    Cohen MV, Liu GS, Downey JM. Preconditioning causes improved wall motion as well as smaller infarct after transient coronary occlusion in rabbit. Circulation 1991; 84: 341349.
  • 15
    Parrat JR. Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation. Trends Pharmacol Sci 1994; 15: 1925.
  • 16
    Vegh A, Szekeres L, Parrat JR. Preconditioning of the ischemic myocardium: involvement of the 1-arginine nitric oxide patway. Br J Pharmacol 1992; 107: 648652.
  • 17
    Lu HR, Remeysen P, DeClerck F. Does the antiarrhytmic effect of ischemic preconditioning in rats involve the L-arginine nitric oxide pathway? J Cardiovasc Pharmacol 1995; 25: 524530.
  • 18
    Van Winkle DM, Downey JM, Thornton JD, Davis RF. Ischemic preconditioning on myocardium: effect of adenosine. In: Maruyama, et al. Recent Advances in Coronary Circulation. Tokyo: Springer-Verlag, 1993: 223234.
  • 19
    Vuorinen K, Ylitalo K. Peuhkurinen K, Raatikaien P, Ala-Rämi, Hassinen IE. Mechanism of ischemic preconditioning in rat myocardium. Circulation 1995; 91: 28102818.
  • 20
    Smits P, Williams SB, Lipson DE, Banitt P, Rongen GA, Creager MA. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation 1995; 92: 21352141.